Thursday, April 02, 2020 5:35:39 PM
Historical Short Volume Data for BRTX
Date Close High Low Volume Short Volume % of Vol Shorted
Mar 23 NA NA NA 150,450,902 66,097,897 43.93
Mar 20 NA NA NA 23,540,033 8,859,900 37.64
Mar 19 NA NA NA 18,295,729 10,034,014 54.84
Mar 18 NA NA NA 17,762,708 9,811,909 55.24
Mar 17 NA NA NA 9,527,702 4,053,044 42.54
Mar 16 NA NA NA 30,844,392 11,788,966 38.22
Mar 13 NA NA NA 40,569,614 24,320,389 59.95
Mar 12 NA NA NA 47,136,540 21,572,371 45.77
Mar 11 NA NA NA 21,944,729 14,945,430 68.10
Mar 10 NA NA NA 59,795,397 33,774,690 56.48
Mar 09 NA NA NA 20,906,541 12,344,332 59.05
Mar 06 NA NA NA 32,921,600 21,836,469 66.33
Mar 05 NA NA NA 21,715,254 15,529,881 71.52
Mar 04 NA NA NA 61,837,902 33,244,483 53.76
Mar 03 NA NA NA 21,287,234 21,078,744 99.02
https://www.otcshortreport.com/company/BRTXQ
Historical Short Volume Data for BRTXQ
Date Close High Low Volume Short Volume % of Vol Shorted
Apr 01 NA NA NA 4,821,221 2,565,221 53.21
Mar 31 NA NA NA 6,282,800 5,067,700 80.66
Mar 30 NA NA NA 19,652,125 10,756,600 54.74
Mar 27 NA NA NA 5,299,106 4,505,000 85.01
Mar 26 NA NA NA 13,613,551 7,450,000 54.72
Mar 25 NA NA NA 71,628,422 64,119,599 89.52
Mar 24 NA NA NA 32,352,872 16,167,949 49.97
C4urself the 1st Ammendment.
Don't assume that i don't know, and i wont assume, that you have no idea.
Recent BRTX News
- BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology • GlobeNewswire Inc. • 04/30/2024 11:30:00 AM
- Biotech Catches Major Premarket Bid Following FDA Clearance • AllPennyStocks.com • 04/16/2024 02:25:00 PM
- BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment • GlobeNewswire Inc. • 04/16/2024 11:45:00 AM
- BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 04/08/2024 11:45:00 AM
- BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants • GlobeNewswire Inc. • 04/03/2024 08:38:00 PM
- BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K • GlobeNewswire Inc. • 04/01/2024 11:45:00 AM
- BioRestorative Therapies to Participate in the 36th Annual ROTH Conference • GlobeNewswire Inc. • 03/11/2024 08:15:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/06/2024 09:34:22 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:43:54 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/15/2024 09:40:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:27:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:25:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:23:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:19:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:17:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:13:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:11:35 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:44:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 02:26:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 01:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:09:49 PM
- BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market • GlobeNewswire Inc. • 02/06/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 01:00:18 PM
- BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease • GlobeNewswire Inc. • 02/05/2024 12:30:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM